• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

免疫肿瘤学的机遇与挑战：2014年至2023年的文献计量分析

Opportunities and challenges of immuno-oncology: A bibliometric analysis from 2014 to 2023.

作者信息

Zhang Siqi, Miao Lina, Tian Xiaoxia, Yang Bingxu, Luo Baoping

机构信息

School of Clinical Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, China.

Department of Oncology, Affiliated Hospital of Hubei University of Chinese Medicine, Wuhan, China.

出版信息

Hum Vaccin Immunother. 2025 Dec;21(1):2440203. doi: 10.1080/21645515.2024.2440203. Epub 2025 Jan 30.

DOI:10.1080/21645515.2024.2440203
PMID:39885669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11792843/
Abstract

The emergence of immuno-oncology (IO) has led to revolutionary changes in the field of cancer treatment. Despite notable advancements in this field, a thorough exploration of its full depth and extent has yet to be performed. This study provides a comprehensive overview of publications pertaining to IO. Publications on IO from 2014 to 2023 were retrieved by searching the Web of Science Core Collection database (WoSCC). VOSviewer software and Citespace software were used for the visualized analysis. A total of 1,874 articles have been published in the IO domain. The number of publications and citations has been increasing annually. This study also examines the primary research directions within the field of IO. In conclusion, this study offers a comprehensive overview of the opportunities and challenges associated with IO, illuminating the current status of research and indicating potential future trajectories in this rapidly progressing field. This study provides a comprehensive survey of the current research status and hot spots within the field of IO. It will assist researchers in comprehending the current research emphasis and development trends in this field and offers guidance for future research directions.

摘要

免疫肿瘤学（IO）的出现给癌症治疗领域带来了革命性变化。尽管该领域取得了显著进展，但对其全部深度和广度的全面探索尚未进行。本研究全面概述了与IO相关的出版物。通过检索科学网核心合集数据库（WoSCC）获取了2014年至2023年期间关于IO的出版物。使用VOSviewer软件和Citespace软件进行可视化分析。IO领域共发表了1874篇文章。出版物数量和被引频次逐年增加。本研究还考察了IO领域内的主要研究方向。总之，本研究全面概述了与IO相关的机遇和挑战，阐明了研究现状，并指出了这个快速发展领域未来的潜在发展轨迹。本研究全面调查了IO领域的当前研究现状和热点。它将帮助研究人员了解该领域当前的研究重点和发展趋势，并为未来的研究方向提供指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/133c/11792843/ad292037981d/KHVI_A_2440203_F0009_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/133c/11792843/9f85024d11f9/KHVI_A_2440203_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/133c/11792843/3fe2fe03ab70/KHVI_A_2440203_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/133c/11792843/80572ebde64e/KHVI_A_2440203_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/133c/11792843/449880f55fb8/KHVI_A_2440203_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/133c/11792843/46613d903a21/KHVI_A_2440203_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/133c/11792843/77a7882dcc00/KHVI_A_2440203_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/133c/11792843/1a2b3cd73ac8/KHVI_A_2440203_F0007_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/133c/11792843/75dc0703cfea/KHVI_A_2440203_F0008_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/133c/11792843/ad292037981d/KHVI_A_2440203_F0009_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/133c/11792843/9f85024d11f9/KHVI_A_2440203_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/133c/11792843/3fe2fe03ab70/KHVI_A_2440203_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/133c/11792843/80572ebde64e/KHVI_A_2440203_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/133c/11792843/449880f55fb8/KHVI_A_2440203_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/133c/11792843/46613d903a21/KHVI_A_2440203_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/133c/11792843/77a7882dcc00/KHVI_A_2440203_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/133c/11792843/1a2b3cd73ac8/KHVI_A_2440203_F0007_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/133c/11792843/75dc0703cfea/KHVI_A_2440203_F0008_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/133c/11792843/ad292037981d/KHVI_A_2440203_F0009_OC.jpg

相似文献

1
Opportunities and challenges of immuno-oncology: A bibliometric analysis from 2014 to 2023.免疫肿瘤学的机遇与挑战：2014年至2023年的文献计量分析
Hum Vaccin Immunother. 2025 Dec;21(1):2440203. doi: 10.1080/21645515.2024.2440203. Epub 2025 Jan 30.
2
Global research trends and focus on immunotherapy for endometrial cancer: a comprehensive bibliometric insight and visualization analysis (2012-2024).子宫内膜癌免疫治疗的全球研究趋势与重点：一项全面的文献计量洞察与可视化分析（2012 - 2024年）
Front Immunol. 2025 Apr 8;16:1571800. doi: 10.3389/fimmu.2025.1571800. eCollection 2025.
3
Research hotspots and frontiers of machine learning in renal medicine: a bibliometric and visual analysis from 2013 to 2024.肾脏医学中机器学习的研究热点与前沿：2013年至2024年的文献计量学与可视化分析
Int Urol Nephrol. 2025 Mar;57(3):907-928. doi: 10.1007/s11255-024-04259-3. Epub 2024 Oct 30.
4
Global trends in tumor-associated neutrophil research: a bibliometric and visual analysis.肿瘤相关中性粒细胞研究的全球趋势：文献计量学与可视化分析
Front Immunol. 2025 Mar 14;16:1478092. doi: 10.3389/fimmu.2025.1478092. eCollection 2025.
5
Research Trends in the Application of Artificial Intelligence in Oncology: A Bibliometric and Network Visualization Study.人工智能在肿瘤学应用中的研究趋势：文献计量学和网络可视化研究。
Front Biosci (Landmark Ed). 2022 Aug 31;27(9):254. doi: 10.31083/j.fbl2709254.
6
Research situation, hot spots, and global trends of melasma therapy: Bibliometric insights and visual analysis from 2000 to 2023.研究现状、热点及全球黄褐斑治疗趋势：2000 年至 2023 年的文献计量学见解和可视化分析。
J Cosmet Dermatol. 2024 Nov;23(11):3667-3683. doi: 10.1111/jocd.16438. Epub 2024 Jun 25.
7
A bibliometric and visualization analysis of global trends and frontiers on macrophages in abdominal aortic aneurysms research.巨噬细胞与腹主动脉瘤研究的全球趋势和前沿的文献计量学和可视化分析。
Medicine (Baltimore). 2024 Oct 25;103(43):e40274. doi: 10.1097/MD.0000000000040274.
8
Worldwide productivity and research trend of publications concerning tumor immune microenvironment (TIME): a bibliometric study.全球肿瘤免疫微环境（TIME）相关出版物的生产力和研究趋势：一项文献计量学研究。
Eur J Med Res. 2023 Jul 10;28(1):229. doi: 10.1186/s40001-023-01195-3.
9
Global trends in tertiary lymphoid structures: a bibliometric analysis from 2014 to 2023.三级淋巴结构的全球趋势：2014年至2023年的文献计量分析
Front Immunol. 2024 Nov 15;15:1475062. doi: 10.3389/fimmu.2024.1475062. eCollection 2024.
10
Application of hydrogels in cancer immunotherapy: a bibliometric analysis.水凝胶在癌症免疫治疗中的应用：文献计量分析。
Front Immunol. 2024 Aug 13;15:1433050. doi: 10.3389/fimmu.2024.1433050. eCollection 2024.

引用本文的文献

1
Knowledge-map and bibliometric analysis of scientific research on FDA-approved Chimeric Antigen Receptor T cell products (2015-2024).美国食品药品监督管理局（FDA）批准的嵌合抗原受体T细胞产品的科学研究知识图谱与文献计量分析（2015 - 2024年）
Discov Oncol. 2025 Aug 3;16(1):1461. doi: 10.1007/s12672-025-03360-y.
2
Trends and visualization analysis of research on MASLD-Related hepatocellular carcinoma: a bibliometric analysis.非酒精性脂肪性肝炎相关肝细胞癌研究的趋势与可视化分析：一项文献计量分析
Discov Oncol. 2025 Jun 11;16(1):1057. doi: 10.1007/s12672-025-02858-9.

本文引用的文献

1
Small molecule inhibitors for cancer immunotherapy and associated biomarkers - the current status.小分子抑制剂在癌症免疫治疗及相关生物标志物中的应用现状。
Front Immunol. 2023 Oct 31;14:1297175. doi: 10.3389/fimmu.2023.1297175. eCollection 2023.
2
Prediction of Tumor Microenvironment Characteristics and Treatment Response in Lung Squamous Cell Carcinoma by Pseudogene OR7E47P-related Immune Genes.通过假基因 OR7E47P 相关免疫基因预测肺鳞状细胞癌的肿瘤微环境特征和治疗反应。
Curr Med Sci. 2023 Dec;43(6):1133-1150. doi: 10.1007/s11596-023-2798-2. Epub 2023 Nov 28.
3
Molecular Mechanisms of Cutaneous Immune-Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitors.
免疫检查点抑制剂诱导的皮肤免疫相关不良事件（irAEs）的分子机制。
Curr Oncol. 2023 Jul 18;30(7):6805-6819. doi: 10.3390/curroncol30070498.
4
Immune checkpoint therapy-current perspectives and future directions.免疫检查点治疗——现状与未来方向。
Cell. 2023 Apr 13;186(8):1652-1669. doi: 10.1016/j.cell.2023.03.006.
5
Long-term response to autologous anti-CD19 chimeric antigen receptor T cells in relapsed or refractory B cell acute lymphoblastic leukemia: a systematic review and meta-analysis.自体抗 CD19 嵌合抗原受体 T 细胞治疗复发或难治性 B 细胞急性淋巴细胞白血病的长期疗效：系统评价和荟萃分析。
Cancer Gene Ther. 2023 Jun;30(6):845-854. doi: 10.1038/s41417-023-00593-3. Epub 2023 Feb 7.
6
Arginase 1 is a key driver of immune suppression in pancreatic cancer.精氨酸酶 1 是胰腺癌中免疫抑制的关键驱动因素。
Elife. 2023 Feb 2;12:e80721. doi: 10.7554/eLife.80721.
7
The Role of Immune Checkpoint Inhibitors in Cancer Therapy.免疫检查点抑制剂在癌症治疗中的作用。
Clin Pract. 2022 Dec 27;13(1):22-40. doi: 10.3390/clinpract13010003.
8
Designing Cancer Immunotherapies That Engage T Cells and NK Cells.设计能同时激活 T 细胞和自然杀伤细胞的癌症免疫疗法。
Annu Rev Immunol. 2023 Apr 26;41:17-38. doi: 10.1146/annurev-immunol-101921-044122. Epub 2022 Nov 29.
9
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non-Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study.KEYNOTE-042 研究中，PD-L1 肿瘤比例分数≥1%的非小细胞肺癌患者中，帕博利珠单抗对比化疗作为一线治疗的 5 年总生存期结果。
J Clin Oncol. 2023 Apr 10;41(11):1986-1991. doi: 10.1200/JCO.21.02885. Epub 2022 Oct 28.
10
Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study.帕博利珠单抗联合或不联合化疗治疗复发性或转移性头颈部鳞状细胞癌：III 期 KEYNOTE-048 研究的更新结果。
J Clin Oncol. 2023 Feb 1;41(4):790-802. doi: 10.1200/JCO.21.02508. Epub 2022 Oct 11.